Can-fite Biopharma Stock Forecast

Sell candidate since Jul 31, 2026

The Can-Fite BioPharma Ltd stock price fell by -3.96% on the last day (Friday, 31st Jul 2026) from $3.28 to $3.15. During the last trading day the stock fluctuated 6.67% from a day low at $3.15 to a day high of $3.36. The price has fallen in 6 of the last 10 days and is down by -7.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -29 thousand shares and in total, 15 thousand shares were bought and sold for approximately $48.13 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.52% during the next 3 months and, with a 90% probability hold a price between $2.64 and $4.47 at the end of this 3-month period.

CANF Signals & Forecast

There are few to no technical positive signals at the moment. The Can-Fite BioPharma Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.19 and $3.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -31.97%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Can-Fite BioPharma Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.97 and $2.92. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Can-Fite BioPharma Ltd finds support just below today's level at $2.97. If this is broken, then the next support from accumulated volume will be at $2.92 and $2.75.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.210 between high and low, or 6.67%. For the last week the stock has had daily average volatility of 4.27%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CANF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Can-Fite BioPharma Ltd to open at $3.22, and during the day (based on 14 day Average True Range), to move between $3.03 and $3.27, which gives a possible trading interval of +/-$0.242 (+/-7.99%) up or down from last closing price. If Can-Fite BioPharma Ltd takes out the full calculated possible swing range there will be an estimated 7.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.32 (5.40%) than the support at $2.97 (5.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Can-Fite BioPharma Ltd stock A Buy?

Can-Fite BioPharma Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.396 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $3.22 ( 2.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk